|
|
|
Volumn 16, Issue 1, 2012, Pages 138-139
|
|
Oncologic drug shortages also in Italy
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANESTHETIC AGENT;
ANTHRACYCLINE;
ANTIBIOTIC AGENT;
ANTINEOPLASTIC AGENT;
CARDIOVASCULAR AGENT;
CARMUSTINE;
CISPLATIN;
CYTARABINE;
ELECTROLYTE;
ETOPOSIDE;
FLUOROURACIL;
GENERIC DRUG;
LORAZEPAM;
METHOTREXATE;
PACLITAXEL;
VINCRISTINE;
VITAMIN;
BONE MARROW TRANSPLANTATION;
BREAST CANCER;
CANCER RESEARCH;
CANCER THERAPY;
CLINICAL TRIAL (TOPIC);
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG MANUFACTURE;
DRUG SHORTAGE;
EPILEPTIC STATE;
HEALTH CARE;
HEALTH CARE AVAILABILITY;
HOSPITAL;
HOSPITAL PURCHASING;
HUMAN;
ITALY;
LETTER;
LEUKEMIA;
LYMPHOMA;
MEDICAL SOCIETY;
NEOPLASM;
TESTIS CANCER;
TREATMENT PLANNING;
UNITED KINGDOM;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
DRUG COSTS;
DRUG INDUSTRY;
GREAT BRITAIN;
HUMANS;
ITALY;
NEOPLASMS;
UNITED STATES;
|
|
EID: 84859835487
PISSN: 11283602
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (15)
|
|
References (5)
|
